Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
moexipril
Description:
An angiotensin-converting enzyme inhibitor medication used to treat hypertension.
Primary topic:
Blood Pressure and Hypertension Studies (39%)
Related topics:
Blood Pressure and Hypertension Studies (39%),
Renin-Angiotensin System Studies (13%),
Analytical Methods in Pharmaceuticals (7%)
Wikidata ID:
wiki/Q2291605
OpenAlex ID:
keywords/moexipril
Chemical reactivity in solid-state pharmaceuticals: formulation implications
2001
·
Stephen R Byrn
, Wei Xu
, et al.
·
Advanced Drug Delivery Reviews
·
300
Clinical Pharmacokinetics and Selective Pharmacodynamics of New Angiotensin Converting Enzyme Inhibitors: An Update
2002
·
Jessica C. Song
, C. Michael White
·
Clinical Pharmacokinetics
·
135
Development and Validation of RP-HPLC Method for Simultaneous Estimation of Moexipril and Hydrochlorothiazide in Bulk and Tablet Dosage Form
2017
·
Rao AL
·
Open Access Journal of Pharmaceutical Research
·
122
PDF
Pharmacologic, Pharmacokinetic, and Therapeutic Differences among ACE Inhibitors
1998
·
C. Michael White
·
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
·
99
PDF
Angiotensin-Converting Enzyme Inhibition in Infarct-Induced Heart Failure in Rats: Bradykinin Versus Angiotensin II
1994
·
H. M. Stauss
, Y.-C. Zhu
, et al.
·
European Journal of Cardiovascular Prevention & Rehabilitation
·
92
Angiotensin-Converting Enzyme Inhibitors
2014
·
Esen Özkaya
, Kurtuluş Didem Yazganoğlu
·
Springer eBooks
·
73
Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started.
1994
·
N Perico
, S C Amuchastegui
, et al.
·
Journal of the American Society of Nephrology
·
71
CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors
2015
·
X Wang
, G Wang
, et al.
·
The Pharmacogenomics Journal
·
64
Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats
1999
·
Alexander Ravati
, Vera Junker
, et al.
·
European Journal of Pharmacology
·
56
Systemic hypertension in postmenopausal women: A clinical approach
2002
·
Enrique Z. Fisman
, Alexander Tenenbaum
, et al.
·
Current Hypertension Reports
·
46
Impact of antihypertensive therapy on postmenopausal osteoporosis: effects of the angiotensin converting enzyme inhibitor moexipril, 17??-estradiol and their combination on the ovariectomy-induced cancellous bone loss in young rats
1995
·
Michael Stimpel
, Yanfei Ma
, et al.
·
Journal of Hypertension
·
44
An Unexpected pH Effect on the Stability of Moexipril Lyophilized Powder
1989
·
Robert G. Strickley
, Gary C. Visor
, et al.
·
Pharmaceutical Research
·
43
Angiotensin‐converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta‐analysis
2023
·
Yiyun Hu
, Ling Liang
, et al.
·
Journal of Clinical Hypertension
·
39
PDF
Evidence for Site-Specific Absorption of a Novel ACE Inhibitor
1989
·
George M. Grass
, William T. Morehead
·
Pharmaceutical Research
·
37
Repurposing the inhibitors of COVID-19 key proteins through molecular docking approach
2021
·
Huda Ahmed Alghamdi
, Syed Awais Attique
, et al.
·
Process Biochemistry
·
31
PDF
Antihypertensive Treatment in Postmenopausal Women: Results from a Prospective, Randomized, Double-Blind, Controlled Study Comparing an ACE Inhibitor (Moexipril) with a Diuretic (Hydrochlorothiazide)
1998
·
Michael Stimpel
, Brigitte Koch
, et al.
·
Cardiology
·
29
Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
1995
·
O Edling
, G Bao
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
29
Impact of antihypertensive therapy on the skeleton: effects of moexipril and hydrochlorothiazide on osteopenia in spontaneously hypertensive ovariectomized rats
1997
·
YF Ma
, M Stimpel
, et al.
·
Journal of Endocrinology
·
27
Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4)
2013
·
Ryan T. Cameron
, Ryan G. Coleman
, et al.
·
Biochemical Pharmacology
·
26
PDF
Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition
2002
·
Theo Pelzer
, Tertia de Jager
, et al.
·
Journal of Hypertension
·
25
Long-term efficacy and safety of moexipril in the treatment of hypertension.
1994
·
W B White
, A A Fox
, et al.
·
PubMed
·
24
Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.
1995
·
W B White
, M Stimpel
·
PubMed
·
23
Pharmacology and Clinical Use of the New ACE‐Inhibitor Moexipril
1995
·
Michael Stimpel
, Rainer Bonn
, et al.
·
Cardiovascular Drug Reviews
·
23
Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations
2012
·
Beata Stanisz
, Katarzyna Regulska
, et al.
·
Drug Development and Industrial Pharmacy
·
22
Simultaneous determination of moexipril and moexiprilat, its active metabolite, in human plasma by gas chromatography-negative-ion chemical ionization mass spectrometry
1995
·
Wilhelm Hammes
, Brigitte Hammes
, et al.
·
Journal of Chromatography B Biomedical Sciences and Applications
·
21
Show more works
View as search
Works count:
177
Citation count:
2,048
Year
Topic
Type